32 results
424B5
ICON Operational Financing Unlimited Co
26 Apr 24
Prospectus supplement for primary offering
9:41am
mission is to improve the lives of patients by accelerating the development of our customers’ drugs and devices through innovative solutions.
We … to ensure we will be considered for all major Phase I-IV projects.
Delivery of our mission and strategy is focused on our four strategic pillars
F-3ASR
Pharmaceutical Research Associates, Inc.
26 Apr 24
Automatic shelf registration (foreign)
8:19am
and public health organizations. Our mission is to improve the lives of patients by accelerating the development of our customers’ drugs and devices
6-K
EX-99.3
ICLR
Icon Plc
12 Jun 23
Notice of Annual General Meeting
8:07am
mission is to improve the lives of patients by accelerating the development of our customers’ drugs and devices through innovative solutions.
We … to ensure we will be considered for all major Phase I-IV projects.
Delivery of our mission and strategy is focused on our four strategic pillars, being (i
6-K
EX-99.3
ICLR
Icon Plc
17 Jun 22
Notice of Annual General Meeting
9:12am
organisations. Our mission is to improve the lives of patients by accelerating the development of our customers’ drugs and devices through innovative … for all major Phase I-IV projects.
Delivery of our mission and strategy is focused on our four strategic pillars, being (i) Patient Access & Engagement (ii
6-K
EX-99.3
env63ybb3vprn18f0
16 Jun 21
Notice of Annual General Meeting
4:16pm
425
xhv75eal
21 May 21
Business combination disclosure
4:17pm
425
6g4zrxj
11 May 21
Business combination disclosure
5:07pm
424B3
5adz220j mdryi
28 Apr 21
Prospectus supplement
12:00am
F-4/A
u0rx4cb1u7h0 lzyx
26 Apr 21
Registration of securities (foreign) (amended)
9:11pm
F-4
3f63lp8bjj4hb71gxn
31 Mar 21
Registration of securities (foreign)
9:09am
425
4ie3i0hr
24 Feb 21
Business combination disclosure
5:15pm
425
qg1kmbn8kt4p2eli
24 Feb 21
Business combination disclosure
5:08pm
425
srmar1
24 Feb 21
Business combination disclosure
5:06pm
6-K
EX-99.3
cnxy nnvrt0aqhlud3lo
9 Jun 20
Current report (foreign)
7:55am
6-K/A
EX-99.1
vat2f86 jr5zlpz93
21 May 19
Current report (foreign) (amended)
3:12pm
6-K
tvubpxykkpkga5 3ko
21 May 19
Ifrs Annual Report 2018
12:24pm